On-skin biosensors for noninvasive monitoring of postoperative free flaps and replanted digits

IF 15.6 1区 医学 Q1 CELL BIOLOGY
Hao Wu, Zhuo Li, Zhao Xu, Xin Huang, Wei Guo, Jun Zhao, Jinwen Zhang, Shaoyu Liu, Miao Tang, Yuqi Qiu, Ganguang Yang, Juntong Zhu, Lili Liu, Yingjie Wu, Wei Lei, Pan Zhou, Zhouping Yin, Zhenbing Chen, Yutian Liu
{"title":"On-skin biosensors for noninvasive monitoring of postoperative free flaps and replanted digits","authors":"Hao Wu,&nbsp;Zhuo Li,&nbsp;Zhao Xu,&nbsp;Xin Huang,&nbsp;Wei Guo,&nbsp;Jun Zhao,&nbsp;Jinwen Zhang,&nbsp;Shaoyu Liu,&nbsp;Miao Tang,&nbsp;Yuqi Qiu,&nbsp;Ganguang Yang,&nbsp;Juntong Zhu,&nbsp;Lili Liu,&nbsp;Yingjie Wu,&nbsp;Wei Lei,&nbsp;Pan Zhou,&nbsp;Zhouping Yin,&nbsp;Zhenbing Chen,&nbsp;Yutian Liu","doi":"10.1126/scitranslmed.abq1634","DOIUrl":null,"url":null,"abstract":"<div >Severe soft tissue defects and amputated digits are clinically common injuries. Primary treatments include surgical free flap transfer and digit replantation, but these can fail because of vascular compromise. Postoperative monitoring is therefore crucial for timely detection of vessel obstruction and survival of replanted digits and free flaps. However, current postoperative clinical monitoring methods are labor intensive and highly dependent on the experience of nurses and surgeons. Here, we developed on-skin biosensors for noninvasive and wireless postoperative monitoring based on pulse oximetry. The on-skin biosensor was made of polydimethylsiloxane with gradient cross-linking to create a self-adhesive and mechanically robust substrate that interfaces with skin. The substrate was shown to exhibit appropriate adhesion on one side for both high-fidelity measurements of the sensor and low risk of peeling injury to delicate tissues. The other side demonstrated mechanical integrity to facilitate flexible hybrid integration of the sensor. Validation studies using a model of vascular obstruction in rats demonstrated the effectiveness of the sensor in vivo. Clinical studies indicated that the on-skin biosensor was accurate and more responsive than current clinical monitoring methods in identifying microvascular conditions. Comparisons with existing monitoring techniques, including laser Doppler flowmetry and micro-lightguide spectrophotometry, further verified the sensor’s accuracy and ability to identify both arterial and venous insufficiency. These findings suggest that this on-skin biosensor may improve postoperative outcomes in free flap and replanted digit surgeries by providing sensitive and unbiased data directly from the surgical site that can be remotely monitored.</div>","PeriodicalId":21580,"journal":{"name":"Science Translational Medicine","volume":"15 693","pages":""},"PeriodicalIF":15.6000,"publicationDate":"2023-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Science Translational Medicine","FirstCategoryId":"3","ListUrlMain":"https://www.science.org/doi/10.1126/scitranslmed.abq1634","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 1

Abstract

Severe soft tissue defects and amputated digits are clinically common injuries. Primary treatments include surgical free flap transfer and digit replantation, but these can fail because of vascular compromise. Postoperative monitoring is therefore crucial for timely detection of vessel obstruction and survival of replanted digits and free flaps. However, current postoperative clinical monitoring methods are labor intensive and highly dependent on the experience of nurses and surgeons. Here, we developed on-skin biosensors for noninvasive and wireless postoperative monitoring based on pulse oximetry. The on-skin biosensor was made of polydimethylsiloxane with gradient cross-linking to create a self-adhesive and mechanically robust substrate that interfaces with skin. The substrate was shown to exhibit appropriate adhesion on one side for both high-fidelity measurements of the sensor and low risk of peeling injury to delicate tissues. The other side demonstrated mechanical integrity to facilitate flexible hybrid integration of the sensor. Validation studies using a model of vascular obstruction in rats demonstrated the effectiveness of the sensor in vivo. Clinical studies indicated that the on-skin biosensor was accurate and more responsive than current clinical monitoring methods in identifying microvascular conditions. Comparisons with existing monitoring techniques, including laser Doppler flowmetry and micro-lightguide spectrophotometry, further verified the sensor’s accuracy and ability to identify both arterial and venous insufficiency. These findings suggest that this on-skin biosensor may improve postoperative outcomes in free flap and replanted digit surgeries by providing sensitive and unbiased data directly from the surgical site that can be remotely monitored.
用于无创监测术后游离皮瓣和再植手指的皮肤生物传感器
严重的软组织缺损和截肢是临床上常见的损伤。主要治疗方法包括外科游离皮瓣转移和断指再植,但这些方法都可能因血管受损而失败。因此,术后监测对于及时发现血管阻塞以及再植指骨和游离皮瓣的存活至关重要。然而,目前的术后临床监测方法需要大量人力,而且高度依赖护士和外科医生的经验。在此,我们开发了基于脉搏血氧仪的无创无线术后监测皮肤生物传感器。皮肤上的生物传感器由聚二甲基硅氧烷制成,并通过梯度交联创造出一种自粘性强、机械坚固的基底,可与皮肤连接。结果表明,基底的一面具有适当的粘附性,既能对传感器进行高保真测量,又能降低剥离对脆弱组织造成伤害的风险。另一面则表现出机械完整性,便于传感器的灵活混合集成。使用大鼠血管阻塞模型进行的验证研究证明了传感器在体内的有效性。临床研究表明,在识别微血管状况方面,皮肤生物传感器比目前的临床监测方法更准确、反应更灵敏。与现有监测技术(包括激光多普勒血流测量法和微光导分光光度法)的比较进一步验证了传感器的准确性以及识别动脉和静脉功能不全的能力。这些研究结果表明,这种皮肤上的生物传感器可直接从手术部位提供可远程监控的敏感而无偏见的数据,从而改善游离皮瓣和再植手指手术的术后效果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Science Translational Medicine
Science Translational Medicine CELL BIOLOGY-MEDICINE, RESEARCH & EXPERIMENTAL
CiteScore
26.70
自引率
1.20%
发文量
309
审稿时长
1.7 months
期刊介绍: Science Translational Medicine is an online journal that focuses on publishing research at the intersection of science, engineering, and medicine. The goal of the journal is to promote human health by providing a platform for researchers from various disciplines to communicate their latest advancements in biomedical, translational, and clinical research. The journal aims to address the slow translation of scientific knowledge into effective treatments and health measures. It publishes articles that fill the knowledge gaps between preclinical research and medical applications, with a focus on accelerating the translation of knowledge into new ways of preventing, diagnosing, and treating human diseases. The scope of Science Translational Medicine includes various areas such as cardiovascular disease, immunology/vaccines, metabolism/diabetes/obesity, neuroscience/neurology/psychiatry, cancer, infectious diseases, policy, behavior, bioengineering, chemical genomics/drug discovery, imaging, applied physical sciences, medical nanotechnology, drug delivery, biomarkers, gene therapy/regenerative medicine, toxicology and pharmacokinetics, data mining, cell culture, animal and human studies, medical informatics, and other interdisciplinary approaches to medicine. The target audience of the journal includes researchers and management in academia, government, and the biotechnology and pharmaceutical industries. It is also relevant to physician scientists, regulators, policy makers, investors, business developers, and funding agencies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书